Pursuant to Regulation 47 of the Listing Regulations, Ajanta Pharma has informed that it enclosed copies of financial results of the Company for the quarter and year ended 31st March 2025 published in Mumbai edition of Business Standard and Navakal on 1st May 2025.
The above information is a part of company’s filings submitted to BSE.